Skip to main content
      RT @drhalafadhil: All respect to Dr.Alarcon
      As she presents her path to rheumatology practice #ACR21 #rheumatology #Rhe

      Dr.Hala Fadhil , MD drhalafadhil

      4 years ago
      All respect to Dr.Alarcon As she presents her path to rheumatology practice #ACR21 #rheumatology #RheumTwitter https://t.co/JKaeUEvqkx
      RT @rheumarhyme: #ACR21 Anti-IFN autoantibodies predisposing patients to severe COVID ...🤔 And can be done with quant

      LiSa ◡̈︎ rheumarhyme

      4 years ago
      #ACR21 Anti-IFN autoantibodies predisposing patients to severe COVID ...🤔 And can be done with quantiferon test! https://t.co/n3h4vpQGdR
      Dr. Cush reviews the news, and kicks off ACR21 learning and how to take in the annual meeting.
      Mysteries behind polyautoimmunity have confounded rheumatologists for decades. One such association, the co-existence of Familial Mediterranean Fever (FMF) and axial spondyloarthritis (axSpA), remains rare. In fact, we believe the rate to be between 0.5% and 7.5%. Two abstracts looking at axSpA and FMF were highlighted during ACR Convergence 2021. 
      Since the start of the pandemic, hydroxychloroquine (HCQ) was forced into the limelight for the prevention/treatment of COVID-19. When it was found to be ineffective for COVID-19 and might cause potential harm, the drug came under closer scrutiny for its safety profile.
      RheumNow’s expanded coverage of the #ACR21 annual meeting is sponsored in part by @bmsnews, @JanssenUS, @Novartis. Al

      Dr. John Cush RheumNow

      4 years ago
      RheumNow’s expanded coverage of the #ACR21 annual meeting is sponsored in part by @bmsnews, @JanssenUS, @Novartis. All content chosen by RheumNow & its Faculty.
      RT @MeralElRamahiMD: @DoctorYasmin concludes her wonderful, innovative keynote address by noting 2 things she would like

      Meral K. El Ramahi, MD MeralElRamahiMD

      4 years ago
      @DoctorYasmin concludes her wonderful, innovative keynote address by noting 2 things she would like to see change moving forward: 1. How we tend to the wellness of providers 2. Improving communication amongst medical colleagues & communication to the public. #ACR21 @RheumNow https://t.co/BdyVgVr0on
      RT @bella_mehta: There is a lot of talk about #COVID19 vaccines, however we don't much about existing vaccines (eg flu)

      Bella Mehta bella_mehta

      4 years ago
      There is a lot of talk about #COVID19 vaccines, however we don't much about existing vaccines (eg flu) in our patients! Much more work to be done here in rheumatology! @DrDavidKarp at #ACR21 opening session @rheumnow
      RT @ericdeinmd: @DoctorYasmin: "Let's talk about the history ... let's build bridges." We individualize approach to trea

      Eric Dein ericdeinmd

      4 years ago
      @DoctorYasmin: "Let's talk about the history ... let's build bridges." We individualize approach to treatments, we should also individualize our conversation about vaccine hesitancy to your patient's specific concerns. @rheumnow #ACR21 https://t.co/1Jxw8l2phB
      RT @drdavidliew: @DoctorYasmin @RheumNow Great discussion #ACR21 @DoctorYasmin: how do we stop panic/misinformation duri

      David Liew drdavidliew

      4 years ago
      @DoctorYasmin @RheumNow Great discussion #ACR21 @DoctorYasmin: how do we stop panic/misinformation during a pandemic? To improve health literacy, we need to learn how to engage better: - understand the issues/public thinking - targeted messaging to different communities - avoid medical hubris @RheumNow https://t.co/FLvPvX3UJc
      RT @ericdeinmd: @DrDavidKarp: "We are learning about #COVID19 vaccine, but we don't know what to do about the other vac

      Eric Dein ericdeinmd

      4 years ago
      @DrDavidKarp: "We are learning about #COVID19 vaccine, but we don't know what to do about the other vaccines." Its a great opportunity for us to learn, research, and educate about the flu, shingles, pneumonia, and more vaccines. 💉 @RheumNow #ACR21
      RT @Yuz6Yusof: "I am often asked when are we going back to normal? NO! I don't want to go back to Normal....we need syst

      Md Yuzaiful Md Yusof Yuz6Yusof

      4 years ago
      "I am often asked when are we going back to normal? NO! I don't want to go back to Normal....we need systems that are more resilient" @DoctorYasmin on lessons learned from #COVID to prepare for future challenges/outbreaks #ACR21 @RheumNow https://t.co/DAdCH80uQ5
      RT @MeralElRamahiMD: @DoctorYasmin notes that anti-vaccination is not a new phenomenon & that we cannot adopt a "one

      Meral K. El Ramahi, MD MeralElRamahiMD

      4 years ago
      @DoctorYasmin notes that anti-vaccination is not a new phenomenon & that we cannot adopt a "one size fits all" method in tackling vaccine hesitancy. She emphasizes the need for targeted messaging & the ideology that vaccination is anti-American must be debunked! #ACR21 @RheumNow https://t.co/cU33XEOYhM
      RT @drdavidliew: "If we go back to business as usual, we will have failed." @DoctorYasmin in the #ACR21 Opening Session.

      David Liew drdavidliew

      4 years ago
      "If we go back to business as usual, we will have failed." @DoctorYasmin in the #ACR21 Opening Session. We need systems that don't need a crisis to shine on them to progressively change for the better. @RheumNow https://t.co/uf4OO2VpHV
      RheumNow’s expanded coverage of the #ACR21 annual meeting is sponsored in part by @Novartis. All content chosen by #Rh

      Dr. John Cush RheumNow

      4 years ago
      RheumNow’s expanded coverage of the #ACR21 annual meeting is sponsored in part by @Novartis. All content chosen by #RheumNow & its Faculty.
      ×